Clinical Trial Update: Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH [Phase 1]

View source ↗

Summary

Phase 1 trial comparing Vecam 40/300 and Vecam 20/300 with omeprazole 20 mg on gastric pH; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Omeprazole 20 mg (Omeprazole 20 mg)
• Vecam 20/300 (Vecam)
• Vecam 40/300 (Vecam)

Snippet

Sponsor: Vecta Ltd. | Conditions: Gastroesophageal Reflux | Phase 1 | Status: COMPLETED